CGS-CIMB Research stays Overweight on glove makers


CGS-CIMB Equities Research is staying Overweight on glove makers as their order book visibility remains strong until 1HCY21F.

KUALA LUMPUR: CGS-CIMB Equities Research is staying Overweight on glove makers as their order book visibility remains strong until 1HCY21F and average selling prices (ASPs) have continued to increase in the near term.

“We understand that most of the glove makers are still increasing their ASPs on a monthly basis due to favourable demand-supply dynamics. Therefore, we believe the increased demand and ASP hikes should lead to sequentially stronger results for all the glove makers, ” it said on Wednesday.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

gloves , Covid-19 , CGS-CIMB Research , vaccine

   

Next In Business News

Companies that might be affected by Trump's promised tariffs
PETRONAS Dagangan share price surges on strong 3Q net profit
Ringgit opens lower against US$ as DXY rebounds
FBM KLCI continues to see upside momentum
Trading ideas: IJM, RHB, MR DIY, Haily, Infomina, Radium, Key Asic, TMK, TopVision, KPJ, PetDag, KLCCP, SP Setia, IOI Prop, MPI
Oil falls more than US$2 a barrel on possible Middle East peace deal
Wall St closes higher; small-caps hit record high after Trump nominates Bessent
Chinese electric vehicle brands are spreading to Azerbaijan
Bond market halts run as buyers pounce on 4.5% yields
Murky 2025 for currently strong US dollar

Others Also Read